Aim Therapeutic hypothermia is standard of care in term infants with moderate‐to‐severe
hypoxic–ischaemic encephalopathy (HIE). The goal of this survey was to explore the …

Abstract Introduction Hypoxic Ischemic Encephalopathy (HIE) can lead to catastrophic
consequences. Published trials mean that Therapeutic Hypothermia has revolutionised …

Objective To characterize the implementation of hypothermia for neonatal hypoxic ischemic
encephalopathy (HIE) in a population-based cohort. Study design Using the California …

Objective To evaluate variations in management of therapeutic hypothermia (TH) for
neonatal hypoxic-ischemic encephalopathy (HIE) among international clinical sites and to …

Objective The use of therapeutic hypothermia (TH) for mild hypoxic–ischaemic
encephalopathy (HIE) remains controversial and inconsistent. We analysed trends in TH …

Peripartum asphyxia complicated by moderate or severe hypoxic–ischaemic
encephalopathy is a devastating global health issue. A therapeutic 'window of …

The time is right to perform a randomized controlled trial (RCT) of neuroprotection for
neonates with mild hypoxic-ischemic encephalopathy (HIE). According to published reports …

Objective To characterize variations in practices and outcomes for neonates with hypoxic-
ischemic encephalopathy (HIE) treated with therapeutic hypothermia (TH) across Canadian …

Aim Therapeutic hypothermia is effective and without serious adverse effects in term infants
with hypoxic–ischaemic encephalopathy. It is unknown whether other neonatal patient …

Objective To compare therapeutic hypothermia (TH) treatment of term and near-term
neonates with hypoxic-ischemic encephalopathy (HIE) between neonatal units. Study …